Vr Adviser, LLC Fulcrum Therapeutics, Inc. Transaction History

Vr Adviser, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $2.43 Million - $12 Million	859,768 Added 192.2%	1,307,094 $3.73 Million
Q4 2022 May 15, 2023	SELL	$5.01 - $8.35 $3.77 Million - $6.28 Million	-752,674 Reduced 62.72%	447,326 $3.26 Million
Q4 2022 Feb 14, 2023	SELL	$5.01 - $8.35 $3.77 Million - $6.28 Million	-752,674 Reduced 62.72%	447,326 $3.26 Million
Q3 2022 May 15, 2023	BUY	$4.92 - $9.1 $3.7 Million - $6.85 Million	752,674 Added 168.26%	1,200,000 $9.54 Million
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $5.9 Million - $10.9 Million	1,200,000 New	1,200,000 $9.71 Million

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $156M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.